当前位置:首页 - 行情中心 - 太龙药业(600222) - 财务分析

太龙药业

(600222)

  

流通市值:40.17亿  总市值:40.17亿
流通股本:5.74亿   总股本:5.74亿

太龙药业(600222)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.23亿元,每股收益0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益165512.40万元,未分配利润29717.58万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产357903.26万元,负债192390.86万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入762,431,550.01323,274,192.261,941,420,111.641,340,673,177.46
营业总成本749,190,272.42322,639,972.491,921,754,800.481,346,043,360.06
其他经营收益
营业利润24,497,216.312,635,627.635,719,330.9324,672,257.41
利润总额24,358,725.72,645,745.5635,074,253.7724,420,992.08
净利润22,601,677.952,631,142.9953,495,468.6929,947,526.3
每股收益
其他综合收益-6,722,238.08-6,596,422.14-17,475,736.43-5,779,588.77
综合收益总额15,879,439.87-3,965,279.1536,019,732.2624,167,937.53
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,010,758,357.311,998,068,813.761,906,060,559.972,150,200,044.79
非流动资产:
非流动资产合计1,568,274,273.041,567,461,961.261,583,707,460.961,574,352,410.2
资产总计3,579,032,630.353,565,530,775.023,489,768,020.933,724,552,454.99
流动负债:
流动负债合计1,555,037,475.851,770,737,645.551,794,514,210.872,001,867,057.93
非流动负债:
非流动负债合计368,871,122.95163,767,952.6269,011,660.68102,748,346.58
负债合计1,923,908,598.81,934,505,598.171,863,525,871.552,104,615,404.51
所有者权益(或股东权益):
归属于母公司股东权益合计1,600,355,674.271,578,411,324.341,574,728,869.81,570,342,251.91
股东权益合计1,655,124,031.551,631,025,176.851,626,242,149.381,619,937,050.48
负债和股东权益合计3,579,032,630.353,565,530,775.023,489,768,020.933,724,552,454.99
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计829,202,591.43417,235,377.161,969,551,608.891,424,290,483.76
经营活动现金流出小计940,884,225.53406,284,927.592,009,137,327.651,521,005,291.43
经营活动产生的现金流量净额-111,681,634.110,950,449.57-39,585,718.76-96,714,807.67
投资活动产生的现金流量:
投资活动现金流入小计145,072,942.3102,107,768.56535,354,774.46505,262,014.93
投资活动现金流出小计54,361,350.7912,662,158.49517,103,819.19409,302,672.88
投资活动产生的现金流量净额90,711,591.5189,445,610.0718,250,955.2795,959,342.05
筹资活动产生的现金流量:
筹资活动现金流入小计1,017,535,766.27424,609,780.951,367,657,239.97870,799,007.07
筹资活动现金流出小计921,975,198.27301,100,699.411,377,433,086.32715,603,814.96
筹资活动产生的现金流量净额95,560,568123,509,081.54-9,775,846.35155,195,192.11
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额74,590,525.41223,905,141.18-31,110,609.84154,439,726.49
期末现金及现金等价物余额218,483,431.26367,798,047.03143,892,905.85329,443,242.18
补充资料:
现金及现金等价物的净增加额74,590,525.41--31,110,609.84-
最新报告期:2025-06-13
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长城证券刘鹏0.110.150.202025-06-13
TOP↑